ZA815133B - Hypoglycemic 5-substituted oxazolidine-2,4-diones - Google Patents

Hypoglycemic 5-substituted oxazolidine-2,4-diones

Info

Publication number
ZA815133B
ZA815133B ZA815133A ZA815133A ZA815133B ZA 815133 B ZA815133 B ZA 815133B ZA 815133 A ZA815133 A ZA 815133A ZA 815133 A ZA815133 A ZA 815133A ZA 815133 B ZA815133 B ZA 815133B
Authority
ZA
South Africa
Prior art keywords
diones
hypoglycemic
substituted oxazolidine
oxazolidine
substituted
Prior art date
Application number
ZA815133A
Other languages
English (en)
Inventor
R Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA815133B publication Critical patent/ZA815133B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA815133A 1980-07-28 1981-07-27 Hypoglycemic 5-substituted oxazolidine-2,4-diones ZA815133B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17320680A 1980-07-28 1980-07-28

Publications (1)

Publication Number Publication Date
ZA815133B true ZA815133B (en) 1982-07-28

Family

ID=22630977

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA815126A ZA815126B (en) 1980-07-28 1981-07-27 Hypoglycemic 5-substituted oxazolidine-2,4-diones
ZA815133A ZA815133B (en) 1980-07-28 1981-07-27 Hypoglycemic 5-substituted oxazolidine-2,4-diones

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA815126A ZA815126B (en) 1980-07-28 1981-07-27 Hypoglycemic 5-substituted oxazolidine-2,4-diones

Country Status (4)

Country Link
JP (1) JPS5758676A (xx)
BE (2) BE889758A (xx)
GT (2) GT198170554A (xx)
ZA (2) ZA815126B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430337A (en) * 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones

Also Published As

Publication number Publication date
ZA815126B (en) 1983-02-23
GT198170555A (es) 1983-01-12
JPS5758676A (en) 1982-04-08
JPS6135188B2 (xx) 1986-08-12
BE889757A (fr) 1982-01-27
BE889758A (fr) 1982-01-27
GT198170554A (es) 1983-01-12

Similar Documents

Publication Publication Date Title
GB2083810B (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
AU7343581A (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
GB2080803B (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
ZA815126B (en) Hypoglycemic 5-substituted oxazolidine-2,4-diones
EP0039920A3 (en) Triazaloquinoxalin-1,4-diones
YU92183A (en) Process for obtaining hypoglycemic 5-substituted oxazolidine-2,4-diones
IE842427L (en) Intermediates for hypoglycemic oxazolidine-2, 4-diones
PH19469A (en) Intermediates for the preparation of hypoglycemic 5-subatituted oxazolidine-2,4-diones
AU555134B2 (en) Intermediates in the preparation of 5-substituted oxazolidine-2, 4-diones
YU92083A (en) Process for obtaining hypoglycemic 5-substituted oxazolodine 2,4-diones